Short-term efficacy of anterior controllable antedisplacement fusion and anterior cervical corpectomy and fusion in treatment of multilevel cervical spondylotic myelopathy with spinal stenosis
Short-term efficacy of anterior controllable antedisplacement fusion and anterior cervical corpectomy and fusion in treatment of multilevel cervical spondylotic myelopathy with spinal stenosis
Objective To evaluate the short-term clinical efficacy of anterior controllable antedisplacement fusion(ACAF)and anterior cervical corpectomy and fusion(ACCF)in the treatment of multilevel cervical spondylotic myelopathy with spinal stenosis(MCSMSS).Methods A retrospective analysis was conducted on the data of 61 MCSMSS patients from June 2021 to June 2022.They were divided into ACAF group(n=28)and ACCF group(n=33)according to surgical methods.The clinical efficacy was evaluated using the Japanese Orthopaedic Association(JOA)score and pain visual analogue scale(VAS)score.The C2-7 Cobb angle before and after surgery was measured to evaluate the recovery of cervical curvature.Intraoperative and postoperative complications were recorded.Results All the operations were successfully completed,and the patients were followed up for more than 6 months.The JOA score,VAS score and C2-7 Cobb angle of the 2 groups improved at the final follow-up compared to pre-operation,and the differences were statistically significant(P＜0.05).At the final follow-up,the JOA score,improvement rate of JOA score and VAS score of the ACAF group were better than those of the ACCF group,and the differences were statistically significant(P＜0.05).The incidence of postoperative complications in the ACAF group was 21.4％(6/28),and 36.4％(12/33)in the ACCF group,and the difference was statistically significant(P＜0.05).At the final follow-up,the fusion rate of surgical segments in both groups was 100％.Conclusions Both ACAF and ACCF have good short-term clinical efficacy in the treatment of MCSMSS.ACAF can be used as an alternative treatment for MCSMSS,but its long-term clinical efficacy still needs further research and evaluation.
维普
万方数据